<?xml version="1.0" encoding="UTF-8"?>
<p>China is currently conducting more than 80 preclinical studies on prospective COVID-19 therapies as well, including a few trials using traditional Chinese herbs [
 <xref rid="B100-plants-09-00800" ref-type="bibr">100</xref>]. There are about 15 experiments identified in Chinaâ€™s database, with more than 2000 estimated participants involved in studies on a number of traditional Chinese therapies. One of largest studies is testing shuanghuanglian, a Chinese herbal medication that includes substances from the dried fruit lianqiao (
 <italic>Forsythiae fructus</italic>), which has reportedly been used to treat infections for more than two millennia. The study involves 400 patients, including an experimental group receiving a normal treatment rather than a placebo therapy.
</p>
